位置:首页 > 蛋白库 > KCNK1_MOUSE
KCNK1_MOUSE
ID   KCNK1_MOUSE             Reviewed;         336 AA.
AC   O08581; Q99L99;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 174.
DE   RecName: Full=Potassium channel subfamily K member 1;
DE   AltName: Full=Inward rectifying potassium channel protein TWIK-1 {ECO:0000303|PubMed:9013852};
GN   Name=Kcnk1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ACTIVITY REGULATION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9013852; DOI=10.1016/s0014-5793(96)01491-3;
RA   Lesage F., Lauritzen I., Duprat F., Reyes R., Fink M., Heurteaux C.,
RA   Lazdunski M.;
RT   "The structure, function and distribution of the mouse TWIK-1 K+ channel.";
RL   FEBS Lett. 402:28-32(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=129/SvJ; TISSUE=Liver;
RX   PubMed=9559671; DOI=10.1016/s0014-5793(98)00260-9;
RA   Arrighi I., Lesage F., Scimeca J.-C., Carle G.F., Barhanin J.;
RT   "Structure, chromosome localization, and tissue distribution of the mouse
RT   twik K+ channel gene.";
RL   FEBS Lett. 425:310-316(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12855359; DOI=10.1016/s0378-5955(03)00162-x;
RA   Nicolas M.T., Barhanin J., Reyes R., Dememes D.;
RT   "Cellular localization of TWIK-1, a two-pore-domain potassium channel in
RT   the rodent inner ear.";
RL   Hear. Res. 181:20-26(2003).
RN   [6]
RP   IDENTIFICATION IN A COMPLEX WITH PSD AND ARF6, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=15540117; DOI=10.1038/sj.embor.7400292;
RA   Decressac S., Franco M., Bendahhou S., Warth R., Knauer S., Barhanin J.,
RA   Lazdunski M., Lesage F.;
RT   "ARF6-dependent interaction of the TWIK1 K+ channel with EFA6, a GDP/GTP
RT   exchange factor for ARF6.";
RL   EMBO Rep. 5:1171-1175(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16025300; DOI=10.1007/s00424-005-1480-9;
RA   Nie X., Arrighi I., Kaissling B., Pfaff I., Mann J., Barhanin J.,
RA   Vallon V.;
RT   "Expression and insights on function of potassium channel TWIK-1 in mouse
RT   kidney.";
RL   Pflugers Arch. 451:479-488(2005).
RN   [8]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=16847696; DOI=10.1007/s00424-006-0107-0;
RA   Millar I.D., Taylor H.C., Cooper G.J., Kibble J.D., Barhanin J., Robson L.;
RT   "Adaptive downregulation of a quinidine-sensitive cation conductance in
RT   renal principal cells of TWIK-1 knockout mice.";
RL   Pflugers Arch. 453:107-116(2006).
RN   [9]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=17079103; DOI=10.1016/j.heares.2006.09.002;
RA   Chen W.C., Davis R.L.;
RT   "Voltage-gated and two-pore-domain potassium channels in murine spiral
RT   ganglion neurons.";
RL   Hear. Res. 222:89-99(2006).
RN   [10]
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=18222039; DOI=10.1016/j.neuroscience.2007.12.011;
RA   Aller M.I., Wisden W.;
RT   "Changes in expression of some two-pore domain potassium channel genes
RT   (KCNK) in selected brain regions of developing mice.";
RL   Neuroscience 151:1154-1172(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF 293-ILE-MET-294.
RX   PubMed=19959478; DOI=10.1074/jbc.m109.078535;
RA   Feliciangeli S., Tardy M.P., Sandoz G., Chatelain F.C., Warth R.,
RA   Barhanin J., Bendahhou S., Lesage F.;
RT   "Potassium channel silencing by constitutive endocytosis and intracellular
RT   sequestration.";
RL   J. Biol. Chem. 285:4798-4805(2010).
RN   [13]
RP   FUNCTION, TISSUE SPECIFICITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22431633; DOI=10.1073/pnas.1201132109;
RA   Chatelain F.C., Bichet D., Douguet D., Feliciangeli S., Bendahhou S.,
RA   Reichold M., Warth R., Barhanin J., Lesage F.;
RT   "TWIK1, a unique background channel with variable ion selectivity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:5499-5504(2012).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=24368895; DOI=10.3389/fncel.2013.00246;
RA   Wang W., Putra A., Schools G.P., Ma B., Chen H., Kaczmarek L.K.,
RA   Barhanin J., Lesage F., Zhou M.;
RT   "The contribution of TWIK-1 channels to astrocyte K(+) current is limited
RT   by retention in intracellular compartments.";
RL   Front. Cell. Neurosci. 7:246-246(2013).
RN   [15]
RP   REVIEW.
RX   PubMed=25530075; DOI=10.1113/jphysiol.2014.287268;
RA   Feliciangeli S., Chatelain F.C., Bichet D., Lesage F.;
RT   "The family of K2P channels: salient structural and functional
RT   properties.";
RL   J. Physiol. (Lond.) 593:2587-2603(2015).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=25406588; DOI=10.1186/s13041-014-0080-z;
RA   Yarishkin O., Lee D.Y., Kim E., Cho C.H., Choi J.H., Lee C.J., Hwang E.M.,
RA   Park J.Y.;
RT   "TWIK-1 contributes to the intrinsic excitability of dentate granule cells
RT   in mouse hippocampus.";
RL   Mol. Brain 7:80-80(2014).
RN   [17]
RP   FUNCTION, SUBUNIT, INTERACTION WITH KCNK2 AND GNG4, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, MUTAGENESIS OF CYS-69 AND GLY-119, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=24496152; DOI=10.1038/ncomms4227;
RA   Hwang E.M., Kim E., Yarishkin O., Woo D.H., Han K.S., Park N., Bae Y.,
RA   Woo J., Kim D., Park M., Lee C.J., Park J.Y.;
RT   "A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive
RT   conductance in astrocytes.";
RL   Nat. Commun. 5:3227-3227(2014).
RN   [18]
RP   REVIEW.
RX   PubMed=25339226; DOI=10.1007/s00424-014-1631-y;
RA   Bichet D., Blin S., Feliciangeli S., Chatelain F.C., Bobak N., Lesage F.;
RT   "Silent but not dumb: how cellular trafficking and pore gating modulate
RT   expression of TWIK1 and THIK2.";
RL   Pflugers Arch. 467:1121-1131(2015).
CC   -!- FUNCTION: Ion channel that contributes to passive transmembrane
CC       potassium transport and to the regulation of the resting membrane
CC       potential in brain astrocytes, but also in kidney and in other tissues
CC       (PubMed:16847696, PubMed:22431633, PubMed:24368895). Forms dimeric
CC       channels through which potassium ions pass in accordance with their
CC       electrochemical gradient. The channel is selective for K(+) ions at
CC       physiological potassium concentrations and at neutral pH, but becomes
CC       permeable to Na(+) at subphysiological K(+) levels and upon
CC       acidification of the extracellular medium. The homodimer has very low
CC       potassium channel activity, when expressed in heterologous systems, and
CC       can function as weakly inward rectifying potassium channel
CC       (PubMed:9013852, PubMed:24496152). Channel activity is modulated by
CC       activation of serotonin receptors (PubMed:24368895). Heterodimeric
CC       channels containing KCNK1 and KCNK2 have much higher activity, and may
CC       represent the predominant form in astrocytes (PubMed:24496152).
CC       Heterodimeric channels containing KCNK1 and KCNK3 or KCNK9 have much
CC       higher activity. Heterodimeric channels formed by KCNK1 and KCNK9 may
CC       contribute to halothane-sensitive currents (By similarity). Mediates
CC       outward rectifying potassium currents in dentate gyrus granule cells
CC       and contributes to the regulation of their resting membrane potential
CC       (PubMed:25406588). Contributes to the regulation of action potential
CC       firing in dentate gyrus granule cells and down-regulates their
CC       intrinsic excitability (PubMed:25406588). In astrocytes, the
CC       heterodimer formed by KCNK1 and KCNK2 is required for rapid glutamate
CC       release in response to activation of G-protein coupled receptors, such
CC       as F2R and CNR1 (PubMed:24496152). Required for normal ion and water
CC       transport in the kidney (PubMed:16025300). Contributes to the
CC       regulation of the resting membrane potential of pancreatic beta cells
CC       (PubMed:22431633). The low channel activity of homodimeric KCNK1 may be
CC       due to sumoylation. The low channel activity may be due to rapid
CC       internalization from the cell membrane and retention in recycling
CC       endosomes (PubMed:15540117). {ECO:0000250|UniProtKB:O00180,
CC       ECO:0000250|UniProtKB:Q9Z2T2, ECO:0000269|PubMed:15540117,
CC       ECO:0000269|PubMed:16025300, ECO:0000269|PubMed:16847696,
CC       ECO:0000269|PubMed:22431633, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:9013852}.
CC   -!- ACTIVITY REGULATION: Inhibited by quinine, quinidine, barium, and
CC       internal acidification. {ECO:0000269|PubMed:9013852,
CC       ECO:0000305|PubMed:16847696}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Both activation and channel closure are very rapid. Is not
CC         voltage-gated (PubMed:22431633, PubMed:24496152). The relationship
CC         between voltage and current is nearly linear (PubMed:22431633,
CC         PubMed:24496152). {ECO:0000269|PubMed:22431633,
CC         ECO:0000269|PubMed:24496152, ECO:0000305};
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:9013852). Heterodimer with
CC       KCNK2; disulfide-linked (PubMed:24496152). In astrocytes, forms mostly
CC       heterodimeric potassium channels with KCNK2, with only a minor
CC       proportion of functional channels containing homodimeric KCNK1 (By
CC       similarity). Interacts with KCNK3 and KCNK9, forming functional
CC       heterodimeric channels (By similarity). Interacts with GNG4
CC       (PubMed:24496152). Identified in a complex with PSD and ARF6; interacts
CC       only with PSD that is bound to ARF6 (PubMed:15540117). Interacts with
CC       UBE2I (By similarity). {ECO:0000250|UniProtKB:O00180,
CC       ECO:0000269|PubMed:15540117, ECO:0000269|PubMed:24496152,
CC       ECO:0000269|PubMed:9013852}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15540117,
CC       ECO:0000269|PubMed:19959478, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:9013852}; Multi-pass
CC       membrane protein {ECO:0000305}. Recycling endosome
CC       {ECO:0000269|PubMed:15540117}. Apical cell membrane
CC       {ECO:0000269|PubMed:12855359, ECO:0000305|PubMed:16025300}. Cytoplasmic
CC       vesicle {ECO:0000269|PubMed:16025300, ECO:0000269|PubMed:24368895}.
CC       Perikaryon {ECO:0000269|PubMed:12855359, ECO:0000269|PubMed:17079103,
CC       ECO:0000269|PubMed:25406588}. Cell projection, dendrite
CC       {ECO:0000269|PubMed:25406588}. Cell projection
CC       {ECO:0000269|PubMed:17079103}. Synaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q9Z2T2}. Note=The heterodimer with KCNK2 is
CC       detected at the astrocyte cell membrane (PubMed:24496152). Not detected
CC       at the astrocyte cell membrane when KCNK2 is absent (PubMed:24496152).
CC       Detected on neuronal cell bodies, and to a lesser degree on neuronal
CC       cell projections (PubMed:12855359, PubMed:17079103). Detected on
CC       hippocampus dentate gyrus granule cell bodies and to a lesser degree on
CC       proximal dendrites (PubMed:25406588). Detected at the apical cell
CC       membrane in stria vascularis in the cochlea (By similarity). Detected
CC       at the apical cell membrane of vestibular dark cells situated between
CC       the crista and the utricle in the inner ear (PubMed:12855359). Detected
CC       at the apical cell membrane in stria vascularis in the cochlea
CC       (PubMed:12855359). Detected at the apical cell membrane in kidney
CC       proximal tubule segment S1 and in subapical compartments in segments
CC       S1, S2 and S3 (PubMed:16025300). Predominantly in cytoplasmic
CC       structures in kidney distal convoluted tubules and collecting ducts
CC       (PubMed:16025300). Predominantly in cytoplasmic structures in
CC       hippocampus astrocytes; only a minor proportion of the protein is
CC       present at the cell membrane (PubMed:24368895).
CC       {ECO:0000250|UniProtKB:Q9Z2T2, ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:17079103, ECO:0000269|PubMed:24368895,
CC       ECO:0000269|PubMed:24496152, ECO:0000269|PubMed:25406588}.
CC   -!- TISSUE SPECIFICITY: Detected in spiral ganglion neurons
CC       (PubMed:17079103). Detected in hippocampus CA1 and CA1 regions and in
CC       the molecular layer of the dentate gyrus (PubMed:24368895,
CC       PubMed:25406588). Detected on hippocampus astrocytes (PubMed:24368895,
CC       PubMed:24496152). Highly expressed in the stria vascularis in the
CC       cochlea (PubMed:12855359). Detected in pancreas islet beta cells
CC       (PubMed:22431633). Detected in kidney, at brush border membranes in
CC       proximal tubules and in cytoplasmic structures in distal convoluted
CC       tubules, thick ascending limbs and collecting ducts (at protein level)
CC       (PubMed:15540117, PubMed:16025300). Widely expressed. Detected in
CC       spiral ganglion cells (PubMed:17079103). Highest expression in brain,
CC       kidney, thyroid, salivary gland, adrenal gland, prostate, epididymis,
CC       uterus, placenta, colon and jejunum. Moderate expression in eyes,
CC       pituitary, pancreas, smooth muscle, testis and ovary. Very low levels
CC       in lung, aorta, liver, heart, skeletal muscle, thymus and spleen. In
CC       the brain, highest expression in cerebellar granule cells, brainstem,
CC       hippocampus and cerebral cortex (PubMed:18222039).
CC       {ECO:0000269|PubMed:15540117, ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:18222039, ECO:0000269|PubMed:22431633,
CC       ECO:0000269|PubMed:24368895, ECO:0000269|PubMed:25406588,
CC       ECO:0000269|PubMed:9013852, ECO:0000269|PubMed:9559671}.
CC   -!- DEVELOPMENTAL STAGE: Detected at very low levels in the embryonic
CC       central nervous system (PubMed:9559671, PubMed:18222039). Detected as
CC       early as 7 days post conception (PubMed:9559671). Detected in dorsal
CC       root ganglia, hippocampus, olfactory epithelia and intestine at 19 dpc
CC       (PubMed:18222039). Expression in the brain increases strongly 3-8 days
CC       after birth, a period of intense postnatal brain development
CC       (PubMed:9559671, PubMed:18222039). Detected in dentate granule cells;
CC       expression levels show no significant variability during postnatal
CC       development (PubMed:18222039). Expression is higher in adults than in
CC       neonates (PubMed:9559671, PubMed:18222039).
CC       {ECO:0000269|PubMed:18222039, ECO:0000269|PubMed:9559671}.
CC   -!- PTM: Sumoylation is controversial. Sumoylated by UBE2I. Not sumoylated
CC       when expressed in xenopus oocytes or mammalian cells. Sumoylation
CC       inactivates the channel, but does not interfere with expression at the
CC       cell membrane. Sumoylation of a single subunit is sufficient to silence
CC       the dimeric channel. Sumoylation of KCNK1 is sufficient to silence
CC       heterodimeric channels formed by KCNK1 and KCNK3 or KCNK9. Desumoylated
CC       by SENP1; this activates the channel. Desumoylated by SENP1; this
CC       strongly increases halothane-mediated activation of heterodimeric
CC       channels formed with KCNK9. SENP1 treatment has no effect.
CC       {ECO:0000250|UniProtKB:O00180}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype on standard chow, excepting
CC       a lower urinary flow rate (PubMed:16025300). Mice appear normal and are
CC       fertile (PubMed:24368895). When kept on a low phosphate diet, both
CC       wild-type and mutant mice show strongly reduced urinary phosphate
CC       secretion. Still, mutant mice display higher fractional urinary
CC       phosphate secretion relative to wild-type, leading to reduced inorganic
CC       phosphate levels in blood plasma. The impaired phosphate homeostasis
CC       seems to be due to indirect effects on the expression of other
CC       transporters, such as SLC34A1 and AQP2 (PubMed:16025300). Principal
CC       cells from kidney collecting duct are hyperpolarized, display reduced
CC       potassium conductance and strongly reduced quinidine-sensitive
CC       potassium channel activity (PubMed:16847696). Besides, collecting ducts
CC       from mutant mouse kidney display a larger diameter relative to wild-
CC       type (PubMed:16847696). {ECO:0000269|PubMed:16025300,
CC       ECO:0000269|PubMed:16847696, ECO:0000269|PubMed:24368895}.
CC   -!- SIMILARITY: Belongs to the two pore domain potassium channel (TC
CC       1.A.1.8) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF033017; AAC16973.1; -; mRNA.
DR   EMBL; CH466525; EDL11808.1; -; Genomic_DNA.
DR   EMBL; BC003729; AAH03729.1; -; mRNA.
DR   CCDS; CCDS22783.1; -.
DR   RefSeq; NP_032456.2; NM_008430.2.
DR   AlphaFoldDB; O08581; -.
DR   SMR; O08581; -.
DR   BioGRID; 200907; 46.
DR   IntAct; O08581; 45.
DR   STRING; 10090.ENSMUSP00000046103; -.
DR   TCDB; 1.A.1.8.1; the voltage-gated ion channel (vic) superfamily.
DR   GlyGen; O08581; 1 site.
DR   iPTMnet; O08581; -.
DR   PhosphoSitePlus; O08581; -.
DR   SwissPalm; O08581; -.
DR   MaxQB; O08581; -.
DR   PaxDb; O08581; -.
DR   PeptideAtlas; O08581; -.
DR   PRIDE; O08581; -.
DR   ProteomicsDB; 263403; -.
DR   Antibodypedia; 20802; 311 antibodies from 32 providers.
DR   DNASU; 16525; -.
DR   Ensembl; ENSMUST00000046765; ENSMUSP00000046103; ENSMUSG00000033998.
DR   GeneID; 16525; -.
DR   KEGG; mmu:16525; -.
DR   UCSC; uc009nyr.3; mouse.
DR   CTD; 3775; -.
DR   MGI; MGI:109322; Kcnk1.
DR   VEuPathDB; HostDB:ENSMUSG00000033998; -.
DR   eggNOG; KOG1418; Eukaryota.
DR   GeneTree; ENSGT00940000155293; -.
DR   HOGENOM; CLU_022504_6_0_1; -.
DR   InParanoid; O08581; -.
DR   OMA; MVAIVHA; -.
DR   OrthoDB; 1211599at2759; -.
DR   PhylomeDB; O08581; -.
DR   TreeFam; TF313947; -.
DR   Reactome; R-MMU-1299308; Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK).
DR   Reactome; R-MMU-5576886; Phase 4 - resting membrane potential.
DR   BioGRID-ORCS; 16525; 5 hits in 72 CRISPR screens.
DR   ChiTaRS; Kcnk1; mouse.
DR   PRO; PR:O08581; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; O08581; protein.
DR   Bgee; ENSMUSG00000033998; Expressed in seminal vesicle and 243 other tissues.
DR   ExpressionAtlas; O08581; baseline and differential.
DR   Genevisible; O08581; MM.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:MGI.
DR   GO; GO:0031526; C:brush border membrane; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IMP:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:1902937; C:inward rectifier potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0034705; C:potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0097060; C:synaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005267; F:potassium channel activity; IDA:MGI.
DR   GO; GO:0022841; F:potassium ion leak channel activity; ISS:UniProtKB.
DR   GO; GO:0005272; F:sodium channel activity; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IC:MGI.
DR   GO; GO:0060075; P:regulation of resting membrane potential; ISS:UniProtKB.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0030322; P:stabilization of membrane potential; IBA:GO_Central.
DR   InterPro; IPR003280; 2pore_dom_K_chnl.
DR   InterPro; IPR003092; 2pore_dom_K_chnl_TASK.
DR   InterPro; IPR005408; 2pore_dom_K_chnl_TWIK.
DR   InterPro; IPR001779; 2pore_dom_K_chnl_TWIK1.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR11003; PTHR11003; 1.
DR   Pfam; PF07885; Ion_trans_2; 2.
DR   PIRSF; PIRSF038061; K_channel_subfamily_K_type; 1.
DR   PRINTS; PR01333; 2POREKCHANEL.
DR   PRINTS; PR01096; TWIK1CHANNEL.
DR   PRINTS; PR01586; TWIKCHANNEL.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Cytoplasmic vesicle; Disulfide bond;
KW   Endosome; Glycoprotein; Ion channel; Ion transport; Isopeptide bond;
KW   Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Ubl conjugation.
FT   CHAIN           1..336
FT                   /note="Potassium channel subfamily K member 1"
FT                   /id="PRO_0000101741"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TRANSMEM        21..41
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        42..103
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   INTRAMEM        104..116
FT                   /note="Helical; Name=Pore helix 1"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   INTRAMEM        117..122
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        123..132
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TRANSMEM        133..156
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        157..181
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TRANSMEM        182..202
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        203..211
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   INTRAMEM        212..224
FT                   /note="Helical; Name=Pore helix 2"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   INTRAMEM        225..231
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        232..243
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TRANSMEM        244..267
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   TOPO_DOM        268..336
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   REGION          117..122
FT                   /note="Selectivity filter 1"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   REGION          225..230
FT                   /note="Selectivity filter 2"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   REGION          293..299
FT                   /note="Important for intracellular retention in recycling
FT                   endosomes"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   REGION          310..336
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            118
FT                   /note="Important for increased permeability to Na(+) when
FT                   K(+) levels are subphysiological"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   SITE            146
FT                   /note="Part of a hydrophobic barrier that is stochastically
FT                   dewetted and limits ion permeability"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   SITE            261
FT                   /note="Part of a hydrophobic barrier that is stochastically
FT                   dewetted and limits ion permeability"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2T2"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        69
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250|UniProtKB:O00180,
FT                   ECO:0000269|PubMed:24496152"
FT   CROSSLNK        274
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:O00180"
FT   MUTAGEN         69
FT                   /note="C->S: Abolishes formation of a disulfide-linked
FT                   heterodimer with KCNK2."
FT                   /evidence="ECO:0000269|PubMed:24496152"
FT   MUTAGEN         119
FT                   /note="G->E: Abolishes potassium channel activity."
FT                   /evidence="ECO:0000269|PubMed:24496152"
FT   MUTAGEN         293..294
FT                   /note="IM->AA: Increases channel expression at the cell
FT                   membrane, resulting in higher channel activity."
FT                   /evidence="ECO:0000269|PubMed:19959478"
FT   CONFLICT        44
FT                   /note="V -> E (in Ref. 1; AAC16973)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="V -> L (in Ref. 1; AAC16973)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="A -> T (in Ref. 1; AAC16973)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   336 AA;  38201 MW;  76B7FD5361A6216C CRC64;
     MLQSLAGSSC VRLVERHRSA WCFGFLVLGY LLYLVFGAVV FSSVELPYED LLRQELRKLK
     RRFLEEHECL SEPQLEQFLG RVLEASNYGV SVLSNASGNW NWDFTSALFF ASTVLSTTGY
     GHTVPLSDGG KAFCIIYSVI GIPFTLLFLT AVVQRVTVHV TRRPVLYFHI RWGFSKQVVA
     IVHAVLLGFV TVSCFFFIPA AVFSVLEDDW NFLESFYFCF ISLSTIGLGD YVPGEGYNQK
     FRELYKIGIT CYLLLGLIAM LVVLETFCEL HELKKFRKMF YVKKDKDEDL VHIMEHDQLS
     FSSVTEQVAG LKEEQKQSEP FVASQSPPYE DGSADH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024